CP
PRCT icon

CenterBook Partners’s Procept Biorobotics PRCT Stock Holding History

CenterBook Partners’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.08M Buy
224,862
+172,192
+327% +$4.31M 0.25% 104
2026
Q1 		$1.32M Buy
+52,670
New +$1.48M 0.07% 307

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CenterBook Partners's PRCT Position: Q2 2026 in Review

CenterBook Partners increased its Procept Biorobotics (PRCT) stake by 327% in Q2 2026, buying an estimated $4.31M and bringing the position to 224,862 shares worth $5.08M. The position accounts for 0.25% of the portfolio, ranked #104.

CenterBook Partners first reported a position in PRCT in Q1 2026 and has held it in 2 quarters since. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • CenterBook Partners held 224,862 shares of Procept Biorobotics worth $5.08M as of Q2 2026.
  • CenterBook Partners bought 172,192 Procept Biorobotics shares in Q2 2026, an estimated $4.31M.
  • Procept Biorobotics made up 0.25% of CenterBook Partners's portfolio in Q2 2026, its #104 holding.
  • CenterBook Partners first reported a position in Procept Biorobotics in Q1 2026 and has held it in 2 quarters since.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.